Quarterly report pursuant to Section 13 or 15(d)

Balance Sheets (Unaudited)

v3.22.2.2
Balance Sheets (Unaudited) - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Current assets    
Cash $ 15,638,087 $ 27,204,269
Acquired patents, net 9,906 12,615
Total assets 15,647,993 27,216,884
Current liabilities    
Accounts payable & accrued interest 220,845 220,845
Unreimbursed expenses 17,034 164,327
Total current liabilities 237,879 385,172
Total liabilities 237,879 385,172
Stockholders’ equity    
Common stock, $0.001 par value; 100,000,000 shares authorized; 12,848,165 and 13,147,829 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively 12,848 13,148
Additional paid-in capital 54,079,520 60,466,093
Accumulated deficit (38,682,254) (33,647,529)
Total stockholders’ equity 15,410,114 26,831,712
Total liabilities and stockholders’ equity $ 15,647,993 $ 27,216,884